HROW
Harrow Health (HROW)
$22
About Harrow Health (HROW)
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Details
Daily high
$35.28
Daily low
$33.75
Price at open
$33.91
52 Week High
$59.23
52 Week Low
$9.13
Market cap
1.2B
Dividend yield
0.00%
Volume
554,342
Avg. volume
384,235
P/E ratio
-36.36
Harrow Health News
Details
Daily high
$35.28
Daily low
$33.75
Price at open
$33.91
52 Week High
$59.23
52 Week Low
$9.13
Market cap
1.2B
Dividend yield
0.00%
Volume
554,342
Avg. volume
384,235
P/E ratio
-36.36